OMER Q1 2020 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$24M+8.1% YoY

Gross Profit

$23M98.9% margin

Operating Income

-$24M-100.6% margin

Net Income

-$29M-123.3% margin

EPS (Diluted)

$-0.53

QoQ Revenue Growth

-29.6%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$118M

Total Liabilities

$250M

Stockholders' Equity

-$132M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$22M	+8.1%
Gross Profit	$23M	$22M	+7.5%
Operating Income	-$24M	-$19M	-23.1%
Net Income	-$29M	-$24M	-19.2%